InvestorsHub Logo
Followers 4
Posts 76
Boards Moderated 0
Alias Born 01/02/2014

Re: cantputt71 post# 21450

Monday, 12/15/2014 11:15:46 PM

Monday, December 15, 2014 11:15:46 PM

Post# of 30990
Dr Mullen inherited multiple messes but he still took over the company and he has brought the right people in and navigated through all the situations he inherited.The question is Why? Why is he here? Why did he want to control the fate and value of Anatabene? He is either very dumb or crazy or he knows something or he did it for the money.Well he is not dumb nor crazy.Was it money? He only makes money if the drug works safely and is approved. I say it's because he wants to make money and he knows something.He knows it works and he knows its safe and will be approved. I believe its more than that.He also wants to help people...he's a doctor. He also wants to find a cure for nuero and brain disease. This will be the culmination of his life's work.He could have made allot more money at Merck.If this fails he makes nothing.

Does anyone really think all those Roskamp scientist spent all those years and believe this is a sham and with that in mind Mullen walked away from Roskamp. Do you think the Roskamp finding were negative or inconclusive?

No...they know...they are sure it works. The key facts are that they are filing on 2 fronts and that they are confident...hence the phase 1 tissue studies which are very unusual!!!! He knows how respected he is in Europe. He knows his contacts there.Look at the depth of Nilvad and who the players are in Nilvad. You think he's a lightweight? He has tremendous clout throughout the finest universities in ALL of Europe.The handwriting is on the wall everyone!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.